Dicembre 2018 - Volume XXXVII - numero 10

Medico e Bambino


Articolo speciale

Malattie rare a cavallo dell’innovazione: una sfida etica e scientifica

Alberto Tommasini, Andrea Magnolato, Serena Pastore, Irene Bruno

Clinica Pediatrica, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste

Indirizzo per corrispondenza: alberto.tommasini@burlo.trieste.it

Rare disease and recent advances in medicine: an ethical and scientific challenge

Key words: Rare diseases, Innovative therapies, Genetic screening, Bioethics

Recent advances in medicine are providing new opportunities to treat rare and complex disorders. Precision therapies are being developed to target molecular processes crucial to the disease pathogenesis. Media often present technological advances raising great hopes. However, the journey on the road of medical innovation can be extremely bumpy for some patients. Indeed, subjects living during a period of innovation and medical changes may just face failures, both in terms of frustrated hopes as well as suffering. Indeed, novel treatments do not always lead to a cure for the disease and the choice to join a clinical trial with innovative medications can be hardly challenging, both as concerns science and humanism. The paper describes four stories of children with rare disorders who had different outcomes and discusses how difficult the best scientific and ethical choices can be when novel treatments are proposed

Vuoi citare questo contributo?

A. Tommasini, A. Magnolato, S. Pastore, I. Bruno Malattie rare a cavallo dell’innovazione: una sfida etica e scientifica. Medico e Bambino 2018;37(10):628 https://www.medicoebambino.com/?id=1810_628.pdf


L'accesso è riservato agli abbonati alla rivista che si siano registrati.
Per accedere all'articolo in formato full text è necessario inserire nella casella di login username e password.

L'immissione di nuovi contenuti è riservata ai soli utenti registrati